INMB vs TSLA · rev $50.0K vs P/E 179, rev $28.24B
INmune Bio Inc (INMB) versus Tesla Inc (TSLA) — a side-by-side from cached financials, not a winner call.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
Tesla Inc (TSLA) is a auto manufacturers company listed on US. It is led by Elon Musk.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
Latest reported TSLA revenue for 2026-06-30 was $28.24B. Net income was $1.11B. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
INMB currently screens at market cap $33.5M. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
Not investment advice. Open the INMB and TSLA stock pages for the full models.
Not investment advice.